Memorial Slone Kettering Cancer Center

New York, New York 10065

2 studies enrolling now · 4 studies all time

What they study most

Advanced Urothelial Carcinoma, Glioma, MAPK Pathway Gene Mutation, MEK Mutation, Malignant Melanoma, Melanoma, NSCLC, Oncology, Open Label, Oral Drug Administration, RAF Gene Mutation, Ras (KRAS or NRAS) Gene Mutation

Studies at this site

• A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma — Recruiting now
• A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors — Recruiting now
• IMCgp100-401 Rollover Study — Stopped early
• Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma — Completed